Pharmacological Application of Phyllanthus emblica as Therapeutics in Alzheimer’s Disease

Avinash Kundadka Kudva, Manjeshwar Shrinath Baliga, Shamprasad Varija Raghu

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Today, neurodegenerative disorders such as Alzheimer’s disease and dementia are affecting millions of people around the world. Although there are treatments available, the success rate is low in achieving the desired therapeutic benefits. Hence, numerous research groups have been working on finding a novel way to treat these disorders. The traditional system of medicine has been in use for centuries. Herbal drugs comprising various plant-based products have been studied and used for treating neurological disorders including Alzheimer’s disease. Phyllanthus emblica has been extensively studied for its therapeutic properties that include antioxidant, anti-inflammatory, anti-hyperlipidemic, anti-diabetic, and neuroprotective actions. These pharmacological actions of Phyllanthus emblica are corroborated by the evidence collected from preclinical research trials. Hence, it deserves the attention of clinical researchers to develop a viable pharmacotherapeutic strategy. The present chapter elaborated the scientific evidence on the pharmacological role of Phyllanthus emblica in conferring protection against Alzheimer’s disease.

Original languageEnglish (US)
Title of host publicationFunctional Foods and Therapeutic Strategies for Neurodegenerative Disorders
PublisherSpringer Nature
Pages51-63
Number of pages13
ISBN (Electronic)9789811667039
ISBN (Print)9789811667022
DOIs
StatePublished - Jan 1 2022

All Science Journal Classification (ASJC) codes

  • General Medicine
  • General Neuroscience

Fingerprint

Dive into the research topics of 'Pharmacological Application of Phyllanthus emblica as Therapeutics in Alzheimer’s Disease'. Together they form a unique fingerprint.

Cite this